Are Prothrombotic Mutations a Time-to-Event Risk Factor?

Lab Med. 2017 Nov 8;48(4):326-331. doi: 10.1093/labmed/lmx046.

Abstract

Background: Deep vein thrombosis (DVT) represents a common disorder involving genetic and acquired risk factors. It has been proposed that acquired risk factors are more important with aging than genetic factors, indicating different prevalence of prothrombotic mutations throughout the lifespan.

Objective: To determine the role of the most frequent prothrombotic genetic risk factors (Factor V [FV] Leiden and Factor II [FII] G20210A mutations) in first-time DVT etiology in patients of different ages.

Method: This retrospective study included 701 patients living in Serbia with diagnosed DVT as a first-time thrombotic event.

Results: Risk assessment for mutations as age-related markers showed no statistical difference (FV Leiden mutation-OR, 1.027; 95% confidence interval [CI], .87-1.22; P = .76 and FII G20210A mutation-OR, 0.940, 95% CI, .74-1.19; P = .61). Our results show similar mutation prevalence regardless of how old the patients were at the time of the first DVT occurrence.

Conclusion: Our results indicate that these 2 mutations cannot be used as prognostic marker for time-to-event first DVT in the Serbian population; however, further studies are required.

Keywords: FII G20210A; FV Leiden; aging; deep venous thrombosis; prognostic marker; thrombophilia.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aging
  • Factor V / genetics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Prothrombin / analysis
  • Retrospective Studies
  • Risk Factors
  • Serbia / epidemiology
  • Venous Thrombosis / epidemiology*
  • Venous Thrombosis / genetics*
  • Young Adult

Substances

  • factor V Leiden
  • Factor V
  • Prothrombin